Exact matches only
Search in title
Search in content
Search in posts
Search in pages
portfolio
Filter by Categories
ADAM
Architecture
Big Data
Bio-IT World
Bioinformatics
Blog
Cases
cBioPortal
Consultancy
CTMM TraIT
Data Curation
Data Management
FAIR
Galaxy
Harry van Haaften
IMI EMIF
IMI ETRIKS
IMI Translocation
Irina Pulyakhina
Janneke Schoots
Jarno van Erp
Jojanneke Blaak
Joris Borgdorff
Kees van Bochove
Maxim Monait
Natalia Boukharov
OMOP and OHDSI
Open source
Peter Kok
Pieter Lukasse
Piotr Zakrzewski
RADAR CNS
Rianne Jansen
Riza Nugraha
Services
Seth Snel
Sjoerd van Hagen
Software Development
Software Engineering
Software licenses
Software licenses
Solutions
Spark
Team
Topics
Translational Research
tranSMART
TranSMART 2.0
Uncategorized
Ward Weistra
Wibo Pipping

@TheHyveNL

It’s been very quiet here at our website since Lisa (who did an internship on a.o. marketing) left us to continue her studies… In contrast, at The Hyve, things have never been more busy than they are right now. Especially over the last few months, we have been growing at an amazing rate, with about 2 new people joining the team every month! The growth is mainly driven by new projects coming in – and thereby shows the success of our story and business model in the market.

Clearly there is something about our offering that resonates very well with a fundamental shift in the markets in which we operate. If it were up to me to indicate what our secret is, I would say it is open innovation at work. The poster case for how open source software can accelerate pre-competitive collaboration (one of the driving forces in the pharma services market at the moment) would still be tranSMART, as I also explained in my earlier post. But we also see a growing interest in other open source platforms that we support, in areas such as biobanking and translational research.

There are two different factors about open source that are interesting for our clients. First of all, it often comes with a cost reduction, and a reduced risk for vendor lock-in. But more importantly, it enables collaboration with parties that would otherwise never be in the picture, such as colleague’s from competitor firms, and researchers from academia, medical centers and hospitals! Here’s a presentation that I recently gave at GDDIS in Princeton: 

Leave a Reply

Your email address will not be published. Required fields are marked *

@TheHyveNL